News Industry News AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot May 26, 2017
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015
News Industry News Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients May 07, 2015